Home | Structured Search | Drug Resource
Find: within
Sexual Assault > Patient Education Author: Carolyn J. Sachs, MD, MPH
Editorial changes - 2009-11-04
Author information and module status
Prevention
Screening
Diagnosis
Consultation for Diagnosis
Hospitalization
Non-drug Therapy
Drug Therapy
Patient Education
Consultation for Management
Follow-up

Tables
Figures
References
Glossary
What's New
Patient Information
Additional Resources
Tools

Rationale:

  • Patients often expect immediate results from the collected specimens, and they need to be informed that evidence may not be examined unless law enforcement expects a reasonable chance of adjudication.
  • Patients may lack a clear understanding of all the STDs that have or have not been addressed with treatments, and this information must be repeated verbally and in written form.
  • Despite easy access to follow-up services, many sexual assault victims fail to obtain medical follow-up examinations and cannot be reached by telephone.
  • Sexual assault precipitates a psychological crisis for the patient, termed rape trauma syndrome.

Evidence:

  • A cross-sectional survey of 103 women showed that patients rarely understand the potential sequelae of STDs or the concept of STD prophylaxis (85).
  • Only 35% of 812 women sexual assault survivors receiving a forensic examination in one center completed a medical follow-up examination (86).
  • A small observational study of female survivors of sexual assault showed the difficulty following up with victims after sexual assault, as less than one-fourth could be reached by telephone 3 months after the initial examination (87).
  • Rape trauma syndrome is a pattern of symptoms, similar to PTSD, first termed by researchers after doing a qualitative observational study of patients who had been raped and who presented to Boston City Hospital (59).

Comments:

  • None.

FAQs
Carolyn J. Sachs, MD, MPH has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.
Steven E. Weinberger, MD, FACP, Acting Editor, PIER, has stock holdings in Glaxosmithkline and Abbott.


The information included herein should never be used as a substitute for clinical judgment and does not represent an official position of ACP. Because all PIER modules are updated regularly, printed web pages or PDFs may rapidly become obsolete. Therefore, PIER users should compare the date of the last update on the website with any printout to ensure that the information being referred to is the most current available.
PIER is copyrighted (c) 2009 by the American College of Physicians,
190 N. Independence Mall West, Philadelphia, PA 19106-1572, USA.